Banner - University Medical Center Phoenix

Summary

Banner - University Medical Center Phoenix is a medical facility located in Phoenix, Arizona. This center is recognized for care of Atrial Fibrillation, Von Willebrand Disease, Heart Failure, Aortic Stenosis, Stroke and other specialties. Banner - University Medical Center Phoenix is involved with conducting 204 clinical trials across 363 conditions. There are 25 research doctors associated with this hospital, such as Michael Morris, MD, Jiaxin Niu, MD, Shakeela Bahadur, and Roderick Tung, MD.

Top PIs

Clinical Trials running at Banner - University Medical Center Phoenix

Heart Failure

Cardiovascular Disease

Cancer

Lung Cancer

Heart Disease

Atrial Fibrillation

Mitral Regurgitation

Stroke

Congestive Heart Failure

Cardio-Renal Syndrome

Mechanical Circulatory Support

for Heart Failure

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

Recruiting

1 award

N/A

3 criteria

CSP ICD Lead

for Heart Failure

This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participating centers from the United States, Canada, Europe, and Asia Pacific.

Recruiting

1 award

N/A

6 criteria

Total Artificial Heart

for Heart Failure

The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular heart failure in which left ventricular assist device (LVAD) support is not recommended, who require mechanical circulatory support to sustain life. The BiVACOR TAH System is intended for use as a bridge to transplant (BTT). Feasibility will be assessed by evaluating safety and performance of the BiVACOR TAH System in study subjects.

Recruiting

1 award

N/A

3 criteria